Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT00469729Phase 2/3Completed
Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy
Acute Myeloid LeukemiaChronic Myeloid LeukemiaHematologic Malignancies+4 more
Principalinvestigator

Research Network

Collaboration Network

25 collaborators·51 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Dr. Mi Kwon, MD

Hospital General Universitario Gregorio Marañon

Very Similar
1 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic Neoplasms+4 more

Worked with same sponsors:

Gamida Cell -Teva Joint Venture Ltd.
Collaborated on 1 trial
Similarity Score74%

Agha Mounzer, MD

University of Pittsburgh Cancer Institute/UPMC Cancer Centers

Very Similar
1 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic Neoplasms+4 more

Worked with same sponsors:

Gamida Cell -Teva Joint Venture Ltd.
Collaborated on 1 trial
Similarity Score74%

Patrick Stiff, MD

Loyola University Cardinal Bernardin Cancer Center

Very Similar
1 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic Neoplasms+4 more

Worked with same sponsors:

Gamida Cell -Teva Joint Venture Ltd.
Collaborated on 1 trial
Similarity Score74%

William Arcese, MD

Universita di Roma Tor Vergata

Very Similar
1 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic Neoplasms+4 more

Worked with same sponsors:

Gamida Cell -Teva Joint Venture Ltd.
Collaborated on 1 trial
Similarity Score74%

Jorge Sierra, MD

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Very Similar
3 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic Neoplasms+4 more

Worked with same sponsors:

Gamida Cell -Teva Joint Venture Ltd.
Collaborated on 1 trial
Similarity Score74%

Guillermo Sanz, MD

Hospital Universitario La Fe

Very Similar
1 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic Neoplasms+4 more

Worked with same sponsors:

Gamida Cell -Teva Joint Venture Ltd.
Collaborated on 1 trial
Similarity Score74%

Mary Territo, MD

UCLA Oncology Center

Very Similar
1 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic Neoplasms+4 more

Worked with same sponsors:

Gamida Cell -Teva Joint Venture Ltd.
Collaborated on 1 trial
Similarity Score74%

Alberto Bosi, MD

Ospedale di Careggi BMT Unit Department of Haematology

Very Similar
1 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic Neoplasms+4 more

Worked with same sponsors:

Gamida Cell -Teva Joint Venture Ltd.
Collaborated on 1 trial
Similarity Score74%

Celia Grosskreutz, MD

Icahn School of Medicine at Mount Sinai

Very Similar
1 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic Neoplasms+4 more

Worked with same sponsors:

Gamida Cell -Teva Joint Venture Ltd.
Collaborated on 1 trial
Similarity Score74%

Christelle Ferra, MD

Germans Trias i Pujol Hospital

Very Similar
1 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic Neoplasms+4 more

Worked with same sponsors:

Gamida Cell -Teva Joint Venture Ltd.
Collaborated on 1 trial
Similarity Score74%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00469729Phase 2/3PrincipalInvestigator

Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy

Acute Myeloid LeukemiaChronic Myeloid LeukemiaHematologic Malignancies+4 more
Completed

All 1 trials loaded